IL10 and myocardial infarction: Firstly, in a mouse model of MI, wild-type EPC-derived exosome treatment was found to improve left ventricle cardiac function, suppress cardiomyocyte apoptosis, reduce MI scar size, and enhance post-MI angiogenesis, whereas IL-10 knockout EPC-derived exosome treatment demonstrated opposite effects.